BioSante Pharmaceuticals, Inc. (BPAX)

[jadite]

Hi Jeff

I decided to respond to this post instead of your new one. IMO the best post of 2013!
This company is not avoiding SEC.They are meeting w/ SEC re CTO which is rarely granted. BPAX CVR holders will be entitled to 82% of initial Libigel revenue.
BOD felt safety was baked into pps and therefore decided to pass expense of safety analysis onto larger group of shareholders
I am encourged and I thank you for taking the initiative to contact Stephen Simes.

I urge anyone who has not read the attached post to read it.

New questions look good too. Thanks for sharing.